Pharmaceutical And Immunollogical Challenge Of Fungal Pathogens
Incidences of fungal infections are on the rise in immunosuppressed people. Predominant causative agents for these mycoses are species of the genus Candida, including Candida albicans, Candida glabrata and Candida dublieniensis. Despite a wide range of emerging pathogens, C. albicans remains the lea...
Main Author: | Stylianou, Marios |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Umeå universitet, Institutionen för klinisk mikrobiologi
2015
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-107713 http://nbn-resolving.de/urn:isbn:978-91-7601-308-3 |
Similar Items
-
Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris
by: Haroldo Cesar de Oliveira, et al.
Published: (2019-04-01) -
Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
by: Madhushree M Routh, et al.
Published: (2013-09-01) -
The Ndr/LATS Kinase Cbk1 Regulates a Specific Subset of Ace2 Functions and Suppresses the Hypha-to-Yeast Transition in Candida albicans
by: Rohan S. Wakade, et al.
Published: (2020-08-01) -
Linking Sfl1 Regulation of Hyphal Development to Stress Response Kinases in Candida albicans
by: Ohimai Unoje, et al.
Published: (2020-01-01) -
Filamentation Involves Two Overlapping, but Distinct, Programs of Filamentation in the Pathogenic Fungus Candida albicans
by: Jahaun Azadmanesh, et al.
Published: (2017-11-01)